Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-03-14)Premium Content

Peregrine Pharmaceuticals Inc (PPHM)

2014-04-11@11:59:45 ET
Progenics Pharmaceuticals has the Highest Beta in the Biotechnology Industry (PGNX, PPHM, VICL) (F70)

2014-04-10@12:28:00 ET
Healthcare Companies Report Results, Patents, and Stock Movements - Analyst Notes on Puma Biotechnology, Alnylam, INSYS Therapeutics, Peregrine Pharmaceuticals, and VIVUS (PRN)

2014-04-09@11:01:05 ET
Data Presented at AACR Support Potential of Peregrine's PS-Targeting Immunotherapy Bavituximab to Enhance Anti-Tumor and Immune-Stimulating Effects of Anti-CTLA-4 and Anti-PD-1 Treatments in Models of Melanoma and Colon Cancer (INW)

2014-04-02@21:22:50 ET
Peregrine Pharmaceuticals CorporationCorporate Event Announcement Notice (WSH)

2014-04-01@21:21:59 ET
Peregrine Pharmaceuticals CorporationCorporate Event Announcement Notice (WSH)

2014-04-01@16:00:54 ET
Peregrine Pharmaceuticals Announces Three Abstracts Accepted for Presentation at AACR 2014 Annual Meeting (INW)

2014-03-24@14:28:10 ET
Stock to Watch: Peregrine Pharmaceuticals Down 9.8% (PPHM) (F77)

2014-03-24@12:43:35 ET
Investors look to Lighten Up on Shares of Peregrine Pharmaceuticals, Shares Down 9.8% (PPHM) (PSM)

2014-03-14@08:01:38 ET
Presentation at Annual Society of Surgical Oncology Meeting Updates Progress in Investigator-Sponsored Phase i/ii Trial of Peregrine's Bavituximab in Combination With Sorafenib in Liver Cancer (INW)

2014-03-13@08:02:08 ET
Preclinical Data Presentations at Keystone Symposia Highlight Broad Immunotherapy Potential of Peregrine Pharmaceuticals' PS-Targeting Antibodies (INW)

2014-03-11@21:53:45 ET
Peregrine Pharmaceuticals CorporationCorporate Event Announcement Notice (WSH)

2014-03-11@16:11:01 ET
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock (INW)

2014-03-11@08:04:03 ET
Data Presentations at Keystone Symposium Support Potential of Peregrine Pharmaceuticals' PS-Targeting Antibodies to Overcome Immune Suppression and Enhance Anti-Tumor Activity of Anti-CTLA-4 and PD-1 Antibodies (INW)

2014-03-10@21:06:47 ET
Peregrine Pharmaceuticals CorporationCorporate Event Announcement Notice (WSH)

2014-03-08@20:53:29 ET
Peregrine Pharmaceuticals CorporationCorporate Event Announcement Notice (WSH)

2014-03-07@22:11:57 ET
Peregrine Pharmaceuticals CorporationCorporate Event Announcement Notice (WSH)

2014-03-07@21:17:06 ET
Peregrine Pharmaceuticals CorporationCorporate Event Announcement Notice (WSH)

2014-03-07@13:33:55 ET
10-Q: PEREGRINE PHARMACEUTICALS INC (EDG)

2014-03-07@09:02:40 ET
US Stocks Gain On Increased Payrolls in February; Foot Locker up on Q4 Beat (MID)

2014-03-07@08:01:24 ET
Peregrine Pharmaceuticals Reports Third Quarter Fiscal Year 2014 Financial Results and Recent Developments (INW)